Omeros Corporation logo
Omeros Corporation OMER
$ 20.08 0.22%
report update icon

Quarterly report 2026-Q2
added 08-12-2026

Omeros Corporation Gross Profit | OMER

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Omeros Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
- - - - - - 111 M 29.4 M 63.7 M 40.2 M 12.5 M - - - 4.52 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
111 M 4.52 M 43.5 M

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
Clovis Oncology Clovis Oncology
CLVS
123 M - -7.23 % $ 13 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
7.9 K - - $ 401 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
1.34 B $ 60.26 0.06 % $ 11.6 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.03 M $ 2.17 0.46 % $ 3.57 M israelIsrael
Genocea Biosciences Genocea Biosciences
GNCA
1.36 K - -15.0 % $ 3.04 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
102 M $ 13.99 0.84 % $ 1.25 B usaUSA
C4 Therapeutics C4 Therapeutics
CCCC
33.2 M $ 2.98 0.3 % $ 247 M usaUSA
Codexis Codexis
CDXS
52.8 M $ 1.32 1.09 % $ 115 M usaUSA
Amryt Pharma plc Amryt Pharma plc
AMYT
116 M - - $ 621 M britainBritain
Cerus Corporation Cerus Corporation
CERS
60.4 M $ 2.62 0.38 % $ 499 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
339 M $ 1.13 0.43 % $ 132 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
5.48 M $ 31.1 1.16 % $ 2.07 B usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
1.54 M $ 4.25 3.16 % $ 51.9 M israelIsrael
AbbVie AbbVie
ABBV
12.1 B $ 264.34 0.09 % $ 468 B usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
7.22 M $ 1.17 1.74 % $ 13.2 M usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
925 K $ 5.4 2.65 % $ 286 M usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
128 M $ 22.53 0.2 % $ 713 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
301 M $ 116.1 4.93 % $ 12.1 B usaUSA
Фармсинтез Фармсинтез
LIFE
160 M - - - russiaRussia
Cardiff Oncology Cardiff Oncology
CRDF
245 K $ 1.24 0.74 % $ 82.9 M usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
3.94 M $ 7.14 0.19 % $ 95.1 M usaUSA
Curis Curis
CRIS
9.5 M $ 0.83 1.1 % $ 10.9 M usaUSA
CorMedix CorMedix
CRMD
276 M $ 7.85 1.03 % $ 565 K usaUSA
Champions Oncology Champions Oncology
CSBR
12.8 M $ 4.9 0.1 % $ 67.8 M usaUSA
Chimerix Chimerix
CMRX
212 K - - $ 756 M usaUSA
Cue Biopharma Cue Biopharma
CUE
3.15 M $ 31.41 1.45 % $ 2.98 B usaUSA
CEL-SCI Corporation CEL-SCI Corporation
CVM
255 K $ 1.67 2.38 % $ 13.4 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-40.6 M $ 4.85 0.2 % $ 929 M canadaCanada
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
-57.6 M $ 64.66 0.17 % $ 7.77 M usaUSA
Daré Bioscience Daré Bioscience
DARE
80 K $ 0.78 4.73 % $ 8.72 M usaUSA